Comparing two pre-transplant treatments for older adults with blood cancers
Treatments studied
Part of Blood & lymphatic, Cancer clinical trials.
This trial compares two conditioning regimens (drug treatments given before a stem cell transplant) to see which one works better and is safer for older adults with certain blood cancers. It may help you if you are between 60 and 75 and are about to get your first transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 60 and 75 years old.
- You must have acute myeloid leukemia in first complete remission or myelodysplastic syndrome.
- This must be your first stem cell transplant.
- You must be in generally good health (able to do daily activities, like light housework or walking).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of chemotherapy drugs before a stem cell transplant for people with acute myeloid leukemia (AML) in first remission who are not very fit or have other health problems. The goal is to make the transplant safer for these patients.
This trial tests adding venetoclax to the usual chemotherapy (fludarabine and melphalan) given before a stem cell transplant for older adults with AML or MDS. The goal is to see if the combination helps prevent the disease from coming back after transplant.
This trial looks back at how older adults with acute myeloid leukemia (AML) did when treated with either standard chemotherapy or a newer combination of venetoclax and decitabine, before a stem cell transplant. The goal is to see which treatment may lead to better outcomes.
This trial tests whether a reduced-intensity stem cell transplant or venetoclax-based pills work better for patients aged 60-75 with high-risk acute myeloid leukemia who are already in remission.
This trial tests a special conditioning regimen (VA) before a stem cell transplant for older patients with higher-risk myelodysplastic syndrome (MDS). It aims to make the transplant safer and more effective for this group.
This trial is testing two different chemotherapy regimens (with one or two alkylating agents) before a stem cell transplant for people with acute myeloid leukemia or myelodysplastic syndrome. The goal is to find which conditioning treatment is safer and more effective.
Hear when a new Older Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.